The DAPA-CKD (Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease) trial specifically included patients with chronic kidney disease with or without diabetes to receive dapagliflozin and found that these patients experienced a lower risk of ESRD, GFR decline of at least 50%, or death from renal or cardiovascular causes in comparison to placebo [31]
Other vital macronutrients like proteins and fats must be included in the diet of athletes with diabetes (11) because, when consumed in moderation, they may marginally raise postprandial blood glucose levels (12) and increase the demand for prandial insulin
Delayed Gastric Emptying Because GLP-1s slow down the rate at which your stomach empties, they can theoretically affect how you absorb other medications
In addition, neuroinflammatory processes in PD are characterized by increased production of proinflammatory cytokines, which may promote further neuronal damage [45]
Dysregulation leads to oxidative stress, promoting inflammation and neurodegeneration